Kanerva J - Search Results

1

Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia.

Nielsen RL, Wolthers BO, Helenius M, Albertsen BK, Clemmensen L, Nielsen K, Kanerva J, Niinimäki R, Frandsen TL, Attarbaschi A, Barzilai S, Colombini A, Escherich G, Aytan-Aktug D, Liu HC, Möricke A, Samarasinghe S, van der Sluis IM, Stanulla M, Tulstrup M, Yadav R, Zapotocka E, Schmiegelow K, Gupta R. Nielsen RL, et al. Among authors: kanerva j. J Pediatr Hematol Oncol. 2022 Apr 1;44(3):e628-e636. doi: 10.1097/MPH.0000000000002292. J Pediatr Hematol Oncol. 2022. PMID: 35226426 Free PMC article.

2

Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL.

Kanerva J, Tiirikainen M, Mäkipernaa A, Riikonen P, Möttönen M, Salmi TT, Krusius T, Saarinen-Pihkala UM. Kanerva J, et al. Pediatr Hematol Oncol. 1998 Jan-Feb;15(1):11-21. doi: 10.3109/08880019809009504. Pediatr Hematol Oncol. 1998. PMID: 9509502

3

Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood acute lymphoblastic leukemia.

Kanerva J, Saarinen-Pihkala UM, Riikonen P, Mäkipernaa A, Möttönen M, Salmi TT. Kanerva J, et al. Med Pediatr Oncol. 1999 Oct;33(4):388-94. doi: 10.1002/(sici)1096-911x(199910)33:4<388::aid-mpo8>3.0.co;2-n. Med Pediatr Oncol. 1999. PMID: 10491548

4

Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up.

Kanerva J, Tiirikainen MI, Mäkipernaa A, Riikonen P, Möttönen M, Salmi TT, Krusius T, Saarinen-Pihkala UM. Kanerva J, et al. Pediatr Hematol Oncol. 2001 Jan-Feb;18(1):27-36. doi: 10.1080/088800101750059837. Pediatr Hematol Oncol. 2001. PMID: 11205837

5

Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study.

Kanerva J, Niini T, Vettenranta K, Riikonen P, Mäkipernaa A, Karhu R, Knuutila S, Saarinen-Pihkala UM. Kanerva J, et al. Med Pediatr Oncol. 2001 Nov;37(5):419-25. doi: 10.1002/mpo.1224. Med Pediatr Oncol. 2001. PMID: 11745869

6

Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia.

Frost BM, Nygren P, Gustafsson G, Forestier E, Jonsson OG, Kanerva J, Nygaard R, Schmiegelow K, Larsson R, Lönnerholm G; Nordic Society for Paediatric Haematology and Oncology. Frost BM, et al. Among authors: kanerva j. Br J Haematol. 2003 Aug;122(3):376-85. doi: 10.1046/j.1365-2141.2003.04442.x. Br J Haematol. 2003. PMID: 12877664 Free article.

7

Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia.

Frost BM, Forestier E, Gustafsson G, Nygren P, Hellebostad M, Jonsson OG, Kanerva J, Schmiegelow K, Larsson R, Lönnerholm G. Frost BM, et al. Among authors: kanerva j. Blood. 2004 Oct 15;104(8):2452-7. doi: 10.1182/blood-2003-12-4426. Epub 2004 Jun 24. Blood. 2004. PMID: 15217836 Free article.

8

High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia.

Skärby TV, Anderson H, Heldrup J, Kanerva JA, Seidel H, Schmiegelow K; Nordic Society of Paediatric Haematology and Oncology (NOPHO). Skärby TV, et al. Among authors: kanerva ja. Leukemia. 2006 Nov;20(11):1955-62. doi: 10.1038/sj.leu.2404404. Epub 2006 Sep 21. Leukemia. 2006. PMID: 16990760

9

Etoposide pharmacokinetics in children treated for acute myeloid leukemia.

Palle J, Frost BM, Gustafsson G, Hellebostad M, Kanerva J, Liliemark E, Schmiegelow K, Lönnerholm G; Nordic Society of Paediatric Haematology and Oncology. Palle J, et al. Among authors: kanerva j. Anticancer Drugs. 2006 Oct;17(9):1087-94. doi: 10.1097/01.cad.0000231470.54288.49. Anticancer Drugs. 2006. PMID: 17001183

10

Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids.

Lönnerholm G, Nordgren A, Frost BM, Jonsson OG, Kanerva J, Nygaard R, Schmiegelow K, Larsson R, Forestier E. Lönnerholm G, et al. Among authors: kanerva j. Leukemia. 2009 Jan;23(1):209-12. doi: 10.1038/leu.2008.179. Epub 2008 Jul 10. Leukemia. 2009. PMID: 18615108 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page